GenRx Entecavir entecavir (as monohydrate) 1mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

entecavir, Quantity: 1 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

Entecavir

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: lactose monohydrate; hyprolose; crospovidone; magnesium stearate; titanium dioxide; iron oxide red; microcrystalline cellulose; macrogol 8000; copovidone; hypromellose

Via di somministrazione:

Oral

Confezione:

30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Dettagli prodotto:

Visual Identification: Pink colored, triangular shaped film coated tablets, engraved 'APO' on one side and '1' over 'ENT' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2016-03-10